Skandinaviska Enskilda Banken (SEB)
PRNB

Skandinaviska Enskilda Banken (SEB)’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,900
Closed -$790K – 1195
2020
Q3 		$790K Sell
7,900
-2,300
-23% -$205K 0.01% 775
2020
Q2 		$610K Buy
+10,200
New +$630K ﹤0.01% 787

Skandinaviska Enskilda Banken (SEB)'s PRNB Position: Q4 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q4 2020, closing a stake of 7,900 shares — an estimated $790K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PRNB in Q2 2020 and held it in 2 quarters. The position peaked at $790K in Q3 2020. 0 funds tracked by Wall St. Rank hold PRNB as of Q4 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Principia Biopharma Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 7,900 Principia Biopharma Inc. Common Stock shares in Q4 2020, an estimated $790K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Principia Biopharma Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Principia Biopharma Inc. Common Stock position peaked at $790K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q4 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2020, filed 11 Feb 2021.